Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.

Kumar A, Gupta R, Varghese T, Pande RM, Singal VK, Garg OP.

Indian J Med Res. 1999 Dec;110:190-3.

PMID:
10701298
2.

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Julkunen H, Ekblom-Kullberg S, Miettinen A.

Rheumatol Int. 2012 Aug;32(8):2445-51. doi: 10.1007/s00296-011-1962-3. Epub 2011 Jun 26.

PMID:
21706294
3.

Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.

Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.

Clin Rheumatol. 2003 Oct;22(4-5):271-8.

PMID:
14576989
4.

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.

Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH.

Lupus. 2012 Jan;21(1):36-42. doi: 10.1177/0961203311422094. Epub 2011 Oct 12.

PMID:
21993384
5.

Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.

Jesus AA, Silva CA, Carneiro-Sampaio M, Sheinberg M, Mangueira CL, Marie SK, Liphaus BL.

Ann N Y Acad Sci. 2009 Sep;1173:235-8. doi: 10.1111/j.1749-6632.2009.04675.x.

PMID:
19758156
6.

Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.

Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B.

Srp Arh Celok Lek. 2014 Jul-Aug;142(7-8):431-6.

7.

Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.

Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH.

Clin Rheumatol. 2011 Jul;30(7):967-73. doi: 10.1007/s10067-011-1698-1. Epub 2011 Feb 23.

PMID:
21340499
8.

Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.

Mok CC, Ho LY, Leung HW, Wong LG.

Transl Res. 2010 Dec;156(6):320-5. doi: 10.1016/j.trsl.2010.07.009. Epub 2010 Aug 20.

PMID:
21078493
9.

Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.

Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.

Scand J Rheumatol. 2007 Jul-Aug;36(4):291-8.

PMID:
17763207
10.

Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.

Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.

Ann Rheum Dis. 2005 Mar;64(3):444-8. Epub 2004 Jul 29.

11.

A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.

Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.

Rheumatol Int. 2013 May;33(5):1193-9. doi: 10.1007/s00296-012-2519-9. Epub 2012 Sep 13.

PMID:
22971892
12.

Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.

Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.

Arthritis Rheum. 2011 Aug;63(8):2436-44. doi: 10.1002/art.30401.

13.

Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.

Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S.

Arthritis Res Ther. 2009;11(3):R87. doi: 10.1186/ar2725. Epub 2009 Jun 10.

14.

Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.

Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.

Ann N Y Acad Sci. 2005 Jun;1050:193-200.

PMID:
16014534
15.

[Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab].

Tsanyan ME, Torgashina AV, Aleksandrova EN, Soloviev SK, Nasonov EL.

Ter Arkh. 2013;85(5):53-9. Russian.

PMID:
23819340
16.

Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.

Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.

Lupus. 2011 Jan;20(1):28-34. doi: 10.1177/0961203310379871. Epub 2010 Oct 13.

PMID:
20943718
17.

Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.

Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC.

Ann Rheum Dis. 1993 Dec;52(12):851-6.

18.

Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus.

Moura CG, Lima I, Barbosa L, Athanazio D, Reis E, Reis M, Burlingame RW, Santiago MB.

J Clin Lab Anal. 2009;23(1):19-23. doi: 10.1002/jcla.20280.

PMID:
19140207
19.

Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.

Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.

J Rheumatol. 2006 Apr;33(4):695-7.

PMID:
16583471
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk